Quality of life assessments in epithelial ovarian cancer patients during and after chemotherapy

International Journal of Gynecological Cancer

Volumn 15, Issue 5, 2005, Pages 811-816

  Le, Tien ^a,b   Hopkins, L ^a   Fung, M Kee Fung ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Chemotherapy; Ovarian cancer; Quality of life

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; TOPOTECAN;

ADULT; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; EMOTION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY METASTASIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM;

FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 28944450411     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00141.x     Document Type: Article

References (13)

1. Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG. Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol 2001;81:490-5.
2. Kornblith AB, Thaler HT, Wong G et al. Quality of life of women with ovarian cancer. Gynecol Oncol 1995;59:231-42.
3. Bodurka-Bevers D, Basen-Engquist K, Carmack CL et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 2000;78(Pt 1):302-8.
4. Hamilton AB. Psychological aspects of ovarian cancer. Cancer Invest 1999;17:335-41.
5. Fitch MI, Gray RE, DePetrillo D, Franssen E, Howell D. Canadian women's perspectives on ovarian cancer. Cancer Prev Control 1999;3:52-60.
6. Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA et al. Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol 2001;19:1809-17.
7. Fitch M, Gray RE, Franssen E. Perspectives on living with ovarian cancer: young women's views. Can Oncol Nurs J 2000;10:101-8.
8. Payne SA. A study of quality of life in cancer patients receiving palliative chemotherapy. Soc Sci Med 1992;35:1505-9.
9. Donovan KA, Greene PG, Shuster JL, Partridge EE, Tucker DC. Treatment preferences in recurrent ovarian cancer. Gynecol Oncol 2002;86:200-11.
10. Wenzel LB, Donnelly JP, Fowler JM et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psycho-oncology 2002;11:142-53.
11. Stewart DE, Wong F, Duff S, Melancon CH, Cheung AM. "What doesn't kill you makes you stronger": an ovarian cancer survivor survey. Gynecol Oncol 2001;83:537-42.
12. Cella D, Hahn E, Dineen K. Meaningful change in cancer specific quality of life score: differences between improvement and worsening. Qual Life Res 2002;11:207-21.
13. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-44.